. Complete ulcer healing was endoscopically confirmed after six weeks in 38 of 41 patients with active ulcer disease at the time of enrolment. The study treatment was well tolerated in most of the treated patients. Four patients (8% of the total study group) complained of side effects resulting from the amoxicillin treatment (exanthema: n=2, mouth buming/ stomatitis: n= 2). In only one patient antibiotics had to be stopped after 10 days. Nevertheless, Hpylori infection was cured in this case.
In patients with a successful cure of H pylorn infection gastric pH was higher during the entire 24 hour period (median gastric pH (10% percentile to 90% percentile): 5-5 (4 2-6.2) v 5.0 (3.5-5.9), p=0.0365), during night time (10 pm to 6 am) (median gastric pH (10% percentile to 90% percentile): 6.3 (4 0-6.9) v 5.5 (2-1-6.4), p=0.0254), and after meals (breakfast, supper) (median gastric pH (10% percentile to 90% percentile): 5.3 (3 8-6 0) v 4.75 (3.25-6.4), p=0 0473), and a decrease of time spent below pH 2, 3, 4, and 5 was observed (Figure; p<0 05 ). There was no statistically significant difference of the median gastric pH during daytime (median gastric pH (10% percentile to 90%/o percentile): 5.5 (4.1-6A1) v 5.2 (3.6-5.9), p=0'1052). A clear cut off point discriminating patients with treatment failure from patients experiencing treatment success does not exist.
The relation between outcome, demographic, and clinical characteristics was subjected to an exploratory analysis. Eradication correlated with drug compliance, smoking, location of the ulcer, age, and grade of body gastritis in an univariate analysis (Table III) , while sex (p=0 148), duration of ulcer disease history (p=0949), complicated ulcer disease (p = 0.117), ulcer disease in remission (p=0-614), pain at the time of enrolment (p= 0. 174), grade of antral gastritis (p=0.118), and activity of antral and body gastritis (p=0-841 and p=0.472, respectively), intake of aspirin or NSAID (p=0 058), alcohol consumption (p =0.749), pre-treatment with antacids or H2 blockers (p=1-00), stay in hospital (p=0.168), and dose of omeprazole (p=0263) were not related to outcome.
Patients with and without active ulcer at the time of enrolment did not differ with regard to ulcer symptoms (epigastric pain: p=025), grade and activity of antral gastritis (p=031 and p=0.28, respectively), grade and activity of body gastritis (p=0.25 and p=063, respectively), and gastric acidity (per cent of time spent below pH 4: p=0.68).
The best predictor of outcome was drug compliance. All patients with insufficient compliance showed ongoing H pylori infection at the final follow up examination. The predictor compliance could not be tested in a multiple logistic regression analysis because of lack of convergence of the likelihood. Of the remaining parameters smoking, per cent time spent below pH 4, and ulcer location (gastric ulcers responded better than duodenal ulcer) were independent predictors of the treatment success (Table III) . Gastric acidity reduction depended on smoking, compliance, location of the ulcer, and age. More time was spent below pH 4 in smokers (p=0.006), non-compliant patients (p=0.037), young patients (p=0.021), and duodenal ulcer patients (p=0.065). Gastric acidity was not related to grade (p=0.81) and activity of body gastritis (p=0-19).
Discussion
We have performed eradication treatment consisting of omeprazole and amoxicillin in ulcer patients infected with H pylori and shown that the success depended on intragastric pH; a higher pH was associated with a higher rate of success. Patients who later turned out to be cured had a median gastric pH of 5.5 while patients with persisting infection had a pH of 5.0. A weakness of our study is the fact that baseline pH measurements are not available. These will be included in future studies. Irrespective of the unknown baseline results, the pH values recorded after one week of eradication treatment will in all likelihood be best suited to rates when omeprazole was combined with amoxicillin or clarithromycin.'5 16 Factors other than ulcer location that influenced gastric acidity were smoking, compliance, and young age. All these factors were not only associated with intragastric acidity, but also with the success of eradication treatment.
It has recently been shown that omeprazole has a stronger antisecretory effect in subjects infected with H pylori than in non-infected subjects.'7 As in our study pH metries were performed one week after the start of the antibiotic treatment, it is probable that many of the successfully treated patients had already cleared their infection and that omeprazole thus may have lost some of its effectiveness. It is therefore probable that the pH difference between cured and uncured patients would have been even more pronounced if we had performed pH metry at the beginning of treatment -that is, when all patients were still infected. This hypothesis will be tested in future studies. On the other hand, duodenal ulcer patients infected with Hpylori have a sixfold increase in both basal and gastrin releasing peptide stimulated acid output, which fully resolves after eradication of the bacteria, but takes up to one year to do so. 18 We performed an exploratory analysis of other predictors to further test the importance of acidity as a predictor of success. Thus, it was shown that the most important predictor was the compliance. Other predictors were smoking (non-smokers responded better than smokers), the location of the ulcer (gastric ulcers responded better than duodenal ulcers), age (eradication rates were higher in old patients than in young patients), and the grade of gastritis in the body (eradication was more frequent when gastritis was more severe). As several of these predictors were also related to gastric acidity, it might be hypothesised that the predictors of Hpylori eradication have, as a common denominator, an effect on acidity. Other types of anti-H pylori treatment, however, seem not to require a reduction of gastric acidity. '9 This may imply that our finding is related to the particular type of antibiotic, amoxicillin, which we have used. As, on the other hand, Hpylori is an acidophilic organism, it will have to be examined whether any type of treatment profits, to some extent, from acid reduction.
We have used two different doses of omeprazole (20 The overall proportion of H pylori eradication in this study was 67% (95% confidence intervals: 52% to 80%), which is somewhat less than previously published by our group.3 13 14 The major drawback of dual therapy comprising omeprazole and amoxicillin is inconsistency of treatment results.2' 22 The published eradication rates varied between 0% and 91%. We have recently statistically analysed our data from 405 patients having been treated with omeprazole plus amoxicillin and have shown by means of multiple logistic regression analysis that lack of compliance, short treatment duration, smoking, and pretreatment with omeprazole were independent risk factors for treatment failure, while old age, gastric ulcer disease, and high scores of grade and of activity of gastritis were independently associated with treatment success.23 In addition, Unge and coworkers have also shown that smoking is an important predictor of outcome and that smoking was frequently associated with poor compliance.5
As in this study compliance could not be tested by regression analysis, smoking may have been a confounding variable. Interestingly, a paper by Zala showed that the deleterious effect of smoking can be abolished by concomitant administration of acetylcysteine clearly suggesting that other factors (for example, free radicals in the stomach of smokers) than higher acidity and poor compliance might be important.24 In this study, the H pylori eradication rate was very low in duodenal ulcer patients treated with omeprazole 80 mg per day plus amoxicillin (H pylori cure rate: 38.5% (95% confidence intervals: 14% to 68%)). Three of these 13 patients had insufficient compliance and nine were smokers. In addition, the scores of body gastritis in this group of patients were lower compared with the group of duodenal ulcer patients having been treated with omeprazole 40 mg per day plus amoxicillin. Less severe body gastritis may theoretically account for an increased acid secretion that has been shown to be a significant predictor of outcome by multiple regression analysis, but our statistical analyses failed to detect a significant relation of grade and of activity gastritis to gastric acidity measured after one week of omeprazole/amoxicillin treatment.
